- Breast Cancer
- Cancer Control
- Chemotherapy
- Diagnostics and Screening
- Gastrointestinal Cancers
- Genitourinary Cancers
- Geriatric Oncology
- Gynecological Oncology
- Head, Neck and Thyroid Cancers
- Hematology
- Hematological Malignancies
- Imaging
- Lung Cancer
- Neurological Cancers
- Pediatric Oncology
- Radiotherapy
- Sarcomas and Melanomas
- Supportive Oncology
Specialties
Fri, 2012-06-01
Thu, 2012-06-14
Thu, 2012-06-28
Latest Testimonial
"Very well done and exciting. Congratulations."
Professor of Medicine and Director
Emili Montserrat
Institute of Hematology and Oncology at the Hospital Clinic of Barcelona
Hematological Malignancies
- Leukaemic Transformation
- Treatment of Myeloproliferative Neoplasms
- Autologous Stem Cell Transplantation
- Blood Stem Cell Mobilisation & Transplantation
Leukaemic Transformation
Leukaemic Transformation of Philadelphia-chromosome-negative Myeloproliferative Neoplasms – A Review of the Molecular Background
Nils H Thoennissen, Phillip Koeffler
European Oncology & Haematology, 2011;7(1):59-62
Treatment of Myeloproliferative Neoplasms
Relevance of Weight Loss, Splenomegaly, and Hypocholesterolemia in the Treatment of Myeloproliferative Neoplasms— Implications for a JAK2 Inhibitor Era
Robyn M Scherber, Ruben A Mesa
US Oncology & Hematology, 2011;7(1):61-3
Autologous Stem Cell Transplantation
Autologous Stem Cell Transplantation—An Important Step Toward Improving Survival in Multiple Myeloma
Ajay Gupta
US Oncological Review, 2010;6(1):24-7
Blood Stem Cell Mobilisation & Transplantation
Comparative Efficacy of Reduced or Standard Doses of Lenograstim for Peripheral Blood Stem Cell Mobilisation and Transplantation – A Review
Mustafa Öztürk, Fikret Arpaci
European Oncology, 2010;6(1):76-9
Editor's choice
Autologous Stem Cell Transplantation—An Important Step Toward Improving Survival in Multiple Myeloma
Ajay Gupta et al.
Oncology & Hematology Review, 2010;6(1):24-27
Also in Editor's Choice











